Annual Operating Expenses
$9.24 M
-$546.50 K-5.59%
30 June 2024
Summary:
InMed Pharmaceuticals annual total operating expenses is currently $9.24 million, with the most recent change of -$546.50 thousand (-5.59%) on 30 June 2024. During the last 3 years, it has fallen by -$703.00 thousand (-7.07%). INM annual operating expenses is now -35.58% below its all-time high of $14.34 million, reached on 30 June 2022.INM Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$2.25 M
-$227.40 K-9.19%
30 September 2024
Summary:
InMed Pharmaceuticals quarterly total operating expenses is currently $2.25 million, with the most recent change of -$227.40 thousand (-9.19%) on 30 September 2024. Over the past year, it has dropped by -$398.00 thousand (-15.04%). INM quarterly operating expenses is now -49.19% below its all-time high of $4.42 million, reached on 31 December 2021.INM Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INM Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.6% | -15.0% |
| 3 y3 years | -7.1% | -22.3% |
| 5 y5 years | -11.1% | -21.9% |
INM Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -35.6% | at low | -49.2% | +10.8% |
| 5 y | 5 years | -35.6% | +0.9% | -49.2% | +44.1% |
| alltime | all time | -35.6% | >+9999.0% | -49.2% | +128.2% |
InMed Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.25 M(-9.2%) |
| June 2024 | $9.24 M(-5.6%) | $2.48 M(+18.7%) |
| Mar 2024 | - | $2.09 M(+2.8%) |
| Dec 2023 | - | $2.03 M(-23.3%) |
| Sept 2023 | - | $2.65 M(+26.8%) |
| June 2023 | $9.78 M(-31.8%) | $2.09 M(-10.9%) |
| Mar 2023 | - | $2.34 M(-1.0%) |
| Dec 2022 | - | $2.37 M(-20.8%) |
| Sept 2022 | - | $2.99 M(-9.4%) |
| June 2022 | $14.34 M(+44.2%) | $3.30 M(-11.4%) |
| Mar 2022 | - | $3.72 M(-15.9%) |
| Dec 2021 | - | $4.42 M(+52.9%) |
| Sept 2021 | - | $2.89 M(-12.5%) |
| June 2021 | $9.94 M(+8.6%) | $3.31 M(+5.5%) |
| Mar 2021 | - | $3.13 M(+62.0%) |
| Dec 2020 | - | $1.93 M(+23.7%) |
| Sept 2020 | - | $1.56 M(+0.2%) |
| June 2020 | $9.15 M(-12.0%) | $1.56 M(-29.2%) |
| Mar 2020 | - | $2.20 M(-12.1%) |
| Dec 2019 | - | $2.51 M(-12.9%) |
| Sept 2019 | - | $2.88 M(-15.2%) |
| June 2019 | $10.39 M(+58.8%) | $3.39 M(+28.5%) |
| Mar 2019 | - | $2.64 M(+23.1%) |
| Dec 2018 | - | $2.15 M(-4.2%) |
| Sept 2018 | - | $2.24 M(-1.3%) |
| June 2018 | $6.55 M(+90.3%) | $2.27 M(+35.9%) |
| Mar 2018 | - | $1.67 M(+35.9%) |
| Dec 2017 | - | $1.23 M(-16.0%) |
| Sept 2017 | - | $1.46 M(-1.8%) |
| June 2017 | $3.44 M(+87.2%) | $1.49 M(+60.3%) |
| Mar 2017 | - | $929.40 K(+32.9%) |
| Dec 2016 | - | $699.40 K(+118.7%) |
| Sept 2016 | - | $319.80 K(-19.3%) |
| June 2016 | $1.84 M(-46.8%) | $396.10 K(+35.0%) |
| Mar 2016 | - | $293.40 K(-47.4%) |
| Dec 2015 | - | $558.30 K(+8.1%) |
| Sept 2015 | - | $516.50 K(-57.5%) |
| June 2015 | $3.46 M(+200.2%) | $1.21 M(-5.0%) |
| Mar 2015 | - | $1.28 M(+161.1%) |
| Dec 2014 | - | $489.70 K(-16.2%) |
| Sept 2014 | - | $584.50 K(-42.4%) |
| June 2014 | $1.15 M(+2365.3%) | $1.01 M(+999.5%) |
| Mar 2014 | - | $92.30 K(+162.2%) |
| Dec 2013 | - | $35.20 K(+220.0%) |
| Sept 2013 | - | $11.00 K(-51.8%) |
| June 2013 | $46.70 K | $22.80 K(+200.0%) |
| Mar 2013 | - | $7600.00(-226.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | -$6000.00(-126.2%) |
| Sept 2012 | - | $22.90 K(-70.1%) |
| June 2012 | $168.60 K(-60.1%) | $76.60 K(+237.4%) |
| Mar 2012 | - | $22.70 K(-13.7%) |
| Dec 2011 | - | $26.30 K(-35.5%) |
| Sept 2011 | - | $40.80 K(-60.3%) |
| June 2011 | $422.50 K(-12.4%) | $102.90 K(-56.4%) |
| Mar 2011 | - | $236.20 K(+541.8%) |
| Dec 2010 | - | $36.80 K(-14.2%) |
| Sept 2010 | - | $42.90 K(-78.8%) |
| June 2010 | $482.10 K(-42.4%) | $202.40 K(+121.7%) |
| Mar 2010 | - | $91.30 K(+4.0%) |
| Dec 2009 | - | $87.80 K(-6.4%) |
| Sept 2009 | - | $93.80 K(-19.8%) |
| June 2009 | $836.50 K(-43.8%) | $116.90 K(+17.7%) |
| Mar 2009 | - | $99.30 K(-61.3%) |
| Dec 2008 | - | $256.80 K(-41.4%) |
| Sept 2008 | - | $438.00 K(-34.3%) |
| June 2008 | $1.49 M(-9.8%) | $666.90 K(+172.0%) |
| Mar 2008 | - | $245.20 K(-54.2%) |
| Dec 2007 | - | $535.40 K(+22.7%) |
| Sept 2007 | - | $436.40 K(-105.5%) |
| June 2007 | $1.65 M(-34.5%) | -$7.98 M(-2933.3%) |
| Mar 2007 | - | $281.80 K(-16.0%) |
| Dec 2006 | - | $335.50 K(-20.0%) |
| Sept 2006 | - | $419.40 K(-23.8%) |
| June 2006 | $2.52 M(-16.9%) | $550.40 K(-1.9%) |
| Mar 2006 | - | $561.30 K(-23.9%) |
| Dec 2005 | - | $737.80 K(+13.3%) |
| Sept 2005 | - | $651.00 K(-14.9%) |
| June 2005 | $3.03 M(+42.0%) | $764.90 K(+20.9%) |
| Mar 2005 | - | $632.90 K(-13.5%) |
| Dec 2004 | - | $731.60 K(-17.3%) |
| Sept 2004 | - | $885.00 K(0.0%) |
| July 2004 | $2.13 M(+55.1%) | $885.00 K(+136.1%) |
| Apr 2004 | - | $374.90 K(-19.4%) |
| Jan 2004 | - | $465.10 K(+1.9%) |
| Oct 2003 | - | $456.40 K(-9.0%) |
| July 2003 | $1.38 M(-49.9%) | $501.50 K(+114.0%) |
| Apr 2003 | - | $234.30 K(-14.1%) |
| Jan 2003 | - | $272.80 K(-15.5%) |
| Oct 2002 | - | $322.70 K(-42.9%) |
| July 2002 | $2.75 M(-35.1%) | $565.40 K(-17.4%) |
| Apr 2002 | - | $684.20 K(-6.2%) |
| Jan 2002 | - | $729.70 K(-3.0%) |
| Oct 2001 | - | $752.60 K |
| July 2001 | $4.24 M | - |
FAQ
- What is InMed Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual operating expenses year-on-year change?
- What is InMed Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals quarterly operating expenses year-on-year change?
What is InMed Pharmaceuticals annual total operating expenses?
The current annual operating expenses of INM is $9.24 M
What is the all time high annual operating expenses for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual total operating expenses is $14.34 M
What is InMed Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, INM annual total operating expenses has changed by -$546.50 K (-5.59%)
What is InMed Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of INM is $2.25 M
What is the all time high quarterly operating expenses for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly total operating expenses is $4.42 M
What is InMed Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, INM quarterly total operating expenses has changed by -$398.00 K (-15.04%)